Clinical Trials on Recipient of Kidney Transplant in Argentina
Total 13 results
-
PfizerCompletedRenal Transplant | Graft Rejection | Kidney Transplant | Renal Allograft RecipientsUnited States, Australia, Germany, Italy, Spain, Brazil, Argentina
-
Novartis PharmaceuticalsCompletedPrevention of Acute Rejection in Paediatric Recipients of a Renal TransplantGermany, United Kingdom, France, Italy, United States, Hungary, Norway, Spain, Argentina, Brazil, Poland, Sweden, Turkey
-
Novartis PharmaceuticalsCompletedLiver Transplant RecipientBelgium, Spain, Germany, Italy, Australia, United States, Netherlands, Ireland, Sweden, Brazil, Colombia, France, Russian Federation, Argentina, Czechia, United Kingdom
-
Paris Translational Research Center for Organ TransplantationCompletedKidney Transplant FailureUnited States, Argentina, Brazil, Chile, Croatia, France, Spain
-
PfizerCompletedKidney TransplantUnited States, Brazil, Australia, South Africa, Germany, Hungary, Poland, Israel, Canada, Austria, Argentina, Mexico
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedKidney TransplantSpain, Italy, Argentina, Greece, Taiwan, Singapore, United States, Canada, United Kingdom, Chile, South Africa, Hungary, Turkey, Austria, Germany, France, Norway, Australia, Sweden, Portugal, Cyprus
-
Novartis PharmaceuticalsCompletedKidney Transplant RejectionUnited States, Hungary, Japan, United Kingdom, Belgium, Spain, Netherlands, Germany, Australia, France, Korea, Republic of, Switzerland, Norway, Italy, Latvia, Sweden, Argentina, Brazil, Canada, Czechia
-
Bio Sidus SAUnknownAnemia of Chronic Kidney DiseaseArgentina, Paraguay
-
Mitsubishi Tanabe Pharma CorporationKureha CorporationCompletedChronic Kidney DiseaseUnited States, Poland, Ukraine, Spain, Argentina, Mexico, Canada, Brazil, Russian Federation, Puerto Rico, Germany, Czechia
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaSpain, Germany, United States, Austria, Czechia, United Kingdom, Argentina, Hungary, France, Canada, Chile
-
Apellis Pharmaceuticals, Inc.Active, not recruitingRenal Transplant | C3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative... and other conditionsUnited States, Australia, Austria, United Kingdom, Brazil, Argentina, France, Italy, Netherlands, Spain, Switzerland
-
GlaxoSmithKlineCompletedAnaemiaUnited States, Canada, France, Russian Federation, Spain, Australia, United Kingdom, Romania, Brazil, Korea, Republic of, Italy, Poland, Argentina, Mexico
-
Novo Nordisk A/SCompletedChronic Kidney Disease | Turner Syndrome | Noonan Syndrome | Chronic Renal Insufficiency | Growth Hormone Disorder | Growth Hormone Deficiency in Children | Adult Growth Hormone Deficiency | Genetic Disorder | Foetal Growth Problem | Small for Gestational AgeIsrael, Saudi Arabia, Spain, Argentina, Russian Federation, Germany, Netherlands, Italy, Belgium, United Kingdom, Slovenia, Ireland, Sweden, Denmark, Hungary, Finland, Norway, France, Czechia, Lithuania, Luxembourg, Serbia, Switzerland